Treatment of 2',6'-di-N-benzyloxycarbony lfortimicin B-1,5-carbamate (7)0 with p-acetamidobcnzenesulfonyl chloride in aqueous acetone in the presence of potassium carbonate gave the desired 4-N-(p-acetamidobenzenesulfonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-l,5-carbamate (8) in 72,,, yield after column chromatography. Both TLC and PMR on the total crude product shoed the absence of starting material 7. Catalytic hydrogenolysis of 8 followed by base-catalyzed hydrolysis gave 4-N-(p-aminobenzenesulfonyl)fortimicin B (3b) which was devoid of antibacterial activity as determined by an in vitro assay. The preparation of 4-N-(2-aminoethanesulfonyl)fortimicin B (3a) was accomplished by a process which involved sulfonylation with 2-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonyl chloride (9a).
The latter was prepared by first treating a pyridine suspension of taurine with 2,2,2-trichloroethoxycarbonyl chloride to give the pyridine salt 9b of 2-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonic acid. The latter 9b was treated with phosphorous pentachloride in chloroform, in a slight modification of the procedure of BARCO, BENETTI, POLLINI and TADDIAB) to give the sulfonyl chloride 9a.
An attempt to effect 4-Ar sulfonylation of the 1,5-carbamate 7 with the sulfonyl chloride 9a in aqueous acetone in the presence of potassium carbonate gave only recovered starting material, which is presumed to be a consequence of hydrolysis of the reagent in the aqueous medium under the reaction conditions. Preliminary attempts to effect 4-N-sulfonylation of 7 with 9a in pyridine established the necessity for protection of the C. -hydroxyl group which was accomplished as follows.
Treatment of 4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10a)'° with excess acetic anhydride in pyridine at room temperature gave a mixture of were successful, the diacetate 10e gave the cleaner product and was thus used in subsequent steps.
Treatment of the sulfonamide 10f, prepared from 10e, with zinc in acetic acid cleaved the trichloroethoxycarbonyl group to give 10g. The latter proved to be water soluble, and transferred completely to the aqueous phase on attempted workup by standard chloroform -aqueous sodium bicarbonate extraction. The product 10g was thus isolated as the acetic acid salt from the zinc -acetic acid cleavage by filtration of the excess zinc, and evaporation of the acetic acid from the filtrate. 
Experimental

General
Optical rotations were determined with a Hilger and Watts polarimeter. IR spectra were recorded using a Perkin-Elmer Model 521 grating spectrometer. PMR spectra were determined at 100 MHz with a Varian Associates HA-100 spectrometer.
Chemical shifts determi4ed with D,O solutions are reported from internal sodium 3-trimethylsilylpropionate 2,2,3,3-d, (TSP). Chemical shifts determined with CDC13 solutions are reported from internal TMS. Mass spectra were obtained on an A.E .I., Table 1 . CMR chemical shifts.* Solutions were about 10% (w/v) in D2O.
M.S. 902 spectrometer at 70 eV and 150" 200°C using the direct probe insert. Silica gel for column chromatography was that of Merck (Darmstadt), 70-230 mesh. Ratios for chromatography solvents are expressed by volume. Workups by chloroform extraction were carried out by shaking the reaction solutions or reaction mixtures with mixtures of chloroform and 5%0 aqueous NaHCO3. The chloroform extracts were separated and dried (MgSO4) and the solvent was evaporated under diminished pressure using a rotary evaporator. The in vitro antibacterial activities of the sulfate salts of 3a and 3b were determined by the serial dilution method using MUELLER-HINTON agar.
1,2',6'-Tri-N-benzyloxycarbonyl-2-O-methanesulfonylfort imicin B (4b) To a stirred solution of 0.5047 g of 1,2',6'-tri-N-benzyloxycarbonylfortimicin B (4a) in 5 ml of pyridine, cooled in an ice bath, was added 0.053 ml of methanesulfonyl chloride. Stirring was continued with cooling for 2 hours and then at ambient temperature for 20 hours. An additional 0.053 ml of methanesulfonyl chloride was added and stirring was continued at room temperature for 21 hours. The product (0.528 g) was isolated by chloroform extraction. PMR and TLC showed that the product, although less pure, was identical with 1,2',6'-tri-N-benzyloxycarbonyl-2-O-methanesulfonylfortimicin B (4b) prepared by an unambiguous method').
A stirred solution of 1.46 g of 2',6'-di-N-benzyloxycarbonylfortimicin B-I,5-carbamate (7)°', 1.05 g of p-acetamidobenzenesulfonyl chloride, 0.620 g of K2C03, 15 nil of water and 42 ml of acetone was kept overnight at room temperature. The product (1.68 g) was isolated by chloroform extraction and chromatographed on a column of 120 g of silica gel prepared and eluted with a solvent system composed of ethyl acetate -ethanol (9: 1) to yield 1.38 g of 4-N-(p-acetamidobenzenesulfonyl)-2',6'-di-.'V-benzyloxycarbonylfortimicin B-1,5-carbamate (8) A solution of 0.820 g of the latter product in 35 ml of 2 N NaOH, under a nitrogen atmosphere was heated at 90°C overnight. The resulting solution was brought to pH 6 by addition of 2 N HCI. The major portion of the solvent was evaporated under reduced pressure, and residual solvent was removed by co-distillation with ethanol under reduced pressure. The residue was triturated with 25 ml of methanol and the insoluble salts were removed by filtration. The filter cake was washed with methanol, and the combined filtrates were evaporated under reduced pressure to leave 1.95 g of residue. The latter was chromatographed on a column of 60 g of silica gel prepared and eluted with a solvent system composed of chloroform -methanol -concentrated ammonium hydroxide (5: 5: 1) to yield 0.544 g of 3b. The latter product (0.510 g) was converted to the trihydrochloride with ethanolic hydrogen chloride, and the salt passed through a column of AGI-X2 (SO4) resin in aqueous solution to give 0.518 g of the sulfate: , 34.89; H, 6.69; N, 9.69; S, 11.09. Found: C, 35.03; H, 6.21 ; N, 9.48; S, 11.58.
Observed peak positions of the AA' BB' system. Both TLC and PMR showed the presence of two components in about a 4: 1 ratio. The PMR spectrum suggested that the major product was the expected 4-N-(p-acetamidobenzenesulfonyl)fortimicin B-1,5-carbamate and that the minor component was 4-N-(p-aminobenzenesulfonyl)fortimicin B-1,5-carbamate. *11`* Observed peak positions of the AA' BB' system . 1981 2-N-(2,2,2-Trichloroethoxycarbonyl)aminoethanesulfonyl chloride (9a) To a stirred suspension of 12.5 g of taurine in 100 ml of pyridine, cooled in an ice bath, was added 2,2,2-trichloroethoxycarbonyl chloride until the reaction mixture became thick and stirring stopped. The reaction mixture was removed from the ice bath and the addition of 2,2,2-trichloroethoxycarbonyl chloride was continued until a total of 15.1 ml had been added. The resulting mixture was kept at room temperature overnight giving a dark red solution. The major portion of the pyridine was evaporated under reduced pressure. Residual pyridine was removed by co-distillation with 1,2-dichloroethane under reduced pressure leaving 54 g of the pyridine salt 9b of 2-N-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonic acid as a dark, red oil. To a stirred solution of the latter 9b in 200 ml of chloroform was added slowly, portionwise, 25 g of PCI5. After the addition was complete, stirring was continued at room temperature for 15 minutes, and the resulting solution was then heated under reflux for 2 hours. The resulting solution was cooled to room temperature, diluted with 200 nil of benzene, and the resulting solution washed with water and dried (MgSO4). The solvent was evaporated under reduced pressure, and residual POCI3 was removed by co-distillation with toluene under reduced pressure. The residue was triturated with hexane and the product (30.4 g), 2-N-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonyl chloride (9a), a white crystalline solid, was collected by filtration: mp 103 -105°C; %ma, (CDC1;) 3441, 3320 (s), 1740 cm-1.
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Anal 2-O-Acetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10b) and 1-N,2-O-Diacetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10d)
A stirred solution of 1.65 g 4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate, 3 ml of acetic anhydride and 25 ml of pyridine was kept overnight at room temperature. The product (1.74 g) was isolated by chloroform extraction and chromatographed on a column of 120 g of silica gel packed and eluted with a solvent system composed of ethyl acetatehexane (7: 3). Earlier fractions gave 0. Anal. Calcd. for C3, H45N4013C13: C, 51.66; H, 5.27; N, 6.52; CI, 12.37. Found: C, 51.28; H, 5.41; N, 6.45; Cl, 12.28 .
A solution of 5.66 g of 2-O-acetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10b), 27 ml of acetic anhydride and 84 ml of pyridine was heated at 60°C for three days. The product (6.00 g) was isolated by chloroform extraction. Chromatography of 6.31 g of product thus prepared on a column of 450 g of silica gel packed and eluted with a solvent system composed of ethyl acetate -hexane (7: 3) gave 5.94 g of l-N,2-O-diacetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfort imicin B-1,5-carbamate (IOd) identical with that prepared as described above.
2_O-Acetyl-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10c) and 2-O-Acetyl-4-N-[2-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonyl]-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10i)
A stirred suspension of 0.838 g of 2-O-acetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10b), 2.2 g of zinc dust and 15 ml of acetic acid was stirred over-night at room temperature and then filtered. The filter cake was washed with ethanol. The combined filtrate and washings was poured into 500 ml of water, and the aqueous suspension was washed twice with 250 ml portions of chloroform. The chloroform extracts were combined, washed with 5 aqueous NaHCO,, and dried (MgSO,). Evaporation of solvent under reduced pressure left 0.499 g of 2-O-acetyl-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10c): o (CDCI,) 1.15 d (J,-,,' 6.5 Hz, C6'-CH,), 2.08 (OCOCH,), 2.37 (NCH,), 3.39 (OCH,).
To a stirred solution of 470 mg of 10c, prepared as described above, in 10 ml of pyridine, cooled in an ice bath, was added 876 mg of 2-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonyl chloride (9a). Stirring was continued with cooling for 1 hour and then at ambient temperature overnight. The product (712 mg) of dark brown glass was isolated by chloroform extraction and chromatographed on a column of 70 g of silica gel packed and eluted with a solvent system composed of ethyl acetate -hexane 
A stirred suspension of 0.400 g of 1-N,2-O-diacetyl-4-N-(2,2,2-trichloroethoxycarbonyl)-2',6'-di-N-benzyloxycarbonylfortimicin B-1,5-carbamate (10d), 1.1 g of zinc dust and 8 ml of acetic acid was kept at room temperature overnight. The mixture was filtered and the filter cake was washed with acetic acid. The combined filtrate and washings were poured into 500 ml of water, and the aqueous suspension was shaken with two 150-ml portions of chloroform. The chloroform extracts were combined, washed with aqueous NaHCO, and dried (MgSO4 To a stirred solution of 3.94 g of 10e, prepared as described above, in 100-m1 of pyridine, cooled in an ice bath, was added 6.92 g of 2-(2,2,2-trichloroethoxycarbonyl)aminoethanesulfonyl chloride (9a). Stirring was continued with cooling for 1 hour and then at ambient temperature overnight. The product (7.04 g) of dark brown glass was isolated by chloroform extraction and chromatographed on a column of 450 g of silica gel packed and eluted with a solvent system composed of ethyl acetate -hexane Anal. Calcd. for C41Hb2N, 016SC1, : C, 48.79; H, 5.19; N, 6.94; S, 3.18; CI, 10.54. Found: C, 49.03; H, 5.29; N, 6.99; S, 3.35; Cl, 10.68 . A stirred solution of 0.800 g of the latter product, 0.283 g of N-(benzyloxycarbonyloxy)succinimide, 0.2 ml of triethylamine, and 30 ml of pyridine was kept at room temperature overnight. The product was isolated by chloroform extraction*. A sample (1.81 g) of product prepared as thus described was dissolved in a solution prepared from 20 ml of 5 % aqueous NaHCO3 and 100 ml of methanol, and the resulting solution was kept at room temperature overnight. The solvent was evaporated under reduced pressure, and residual water was removed by co-distillation with ethanol under reduced pressure. The residue was triturated several times with chloroform. The chloroform supernatants were combined and the chloroform was evaporated under reduced pressure to leave 1.61 g of residue.
The latter was chromatographed on a column of 130 g of silica gel packed and eluted with a solvent system composed of ethyl acetate -ethanol The latter product (0.350 g) was dissolved in 35 ml of I N NaOH and the resulting stirred solution was heated at 80°C for 4 hours under nitrogen. The solution was cooled to room temperature and brought to pH 6 by addition of I N hydrochloric acid. The major portion of the solvent was evaporated under reduced pressure, and residual water was removed by co-distillation with ethanol under reduced pressure. The residue was triturated with methanol and the suspension was filtered. The methanol was evaporated from the filtrate under reduced pressure leaving 1.05 g of residue. The latter was chromatographed on a column of 40 g of silica gel packed and eluted with a solvent system composed of chloroform -methanol -concentrated ammonium hydroxide (10: 10: 1) to give 0.316 g of residue. The latter (0.250 g) was converted to the tetrahydrochloride with excess 0.2 N hydrochloric acid in methanol. An aqueous solution of the resulting salt was passed over a column of AGI-X2 
